• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lnc-SNHG1 和 miR-216b-5p 的失调与化疗耐药相关,并预示浆液性上皮性卵巢癌的不良预后。

Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.

机构信息

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, 710061, China.

Department of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.

出版信息

J Ovarian Res. 2020 Dec 10;13(1):144. doi: 10.1186/s13048-020-00750-4.

DOI:10.1186/s13048-020-00750-4
PMID:33302997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7731520/
Abstract

AIM

This study aimed to explore whether the dysregulation of lnc-small nucleolar RNA host gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor prognosis of serous epithelial ovarian cancer (EOC).

METHODS AND RESULTS

The expression of lnc-SNHG1 was upregulated, while miR-216b-5p showed low expression in patients with chemoresistant EOC compared with patients with chemosensitive EOC. The multivariate Cox regression analysis showed that the expression of miR-216b-5p and FIGO stage were independent prognostic factors for the overall survival (OS) of patients with serous EOC. Kaplan-Meier curves revealed a significant association of the increased expression level of lnc-SNHG1 with shorter OS and disease-free survival (DFS). Patients with a low expression level of miR-216b-5p also had shorter OS and DFS. The biological functions were tested using CCK-8 assay, colony formation assay, wound healing assay, and cell apoptosis. The knockdown of SNHG1 and the overexpression of miR-216b-5p stimulated paclitaxel sensitivity in A2780/Taxol cells through inhibiting cell growth and migration and promoting apoptosis. The inhibition of miR-216b-5p could rescue the effect of lnc-SNHG1 inhibition on the sensitivity of A2780/Taxol cells to paclitaxel. Luciferase reporter assay, RNA Binding Protein Immunoprecipitation Assay (RIP), and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) indicated that lnc-SNHG1 acted as a sponge of miR-216b-5p in A2780/Taxol cells.

CONCLUSIONS

This study showed that the overexpression of lnc-SNHG1 and decreased expression level of miR-216b-5p correlated with the chemoresistance of patients with serous EOC and indicated shorter OS and DFS. Lnc-SNHG1 functioned as a ceRNA with miR-216b-5p, which was critical in modulating the paclitaxel sensitivity of ovarian cancer cells.

摘要

目的

本研究旨在探讨长链非编码 RNA 小核仁 RNA 宿主基因 1(SNHG1)和 miR-216b-5p 的失调是否与上皮性卵巢癌(EOC)的化疗耐药相关,并提示预后不良。

方法和结果

与化疗敏感的 EOC 患者相比,化疗耐药的 EOC 患者中 lnc-SNHG1 的表达上调,而 miR-216b-5p 的表达水平较低。多变量 Cox 回归分析显示,miR-216b-5p 的表达和FIGO 分期是影响浆液性 EOC 患者总生存期(OS)的独立预后因素。Kaplan-Meier 曲线显示,lnc-SNHG1 表达水平升高与 OS 和无病生存期(DFS)较短显著相关。miR-216b-5p 低表达的患者 OS 和 DFS 也较短。通过 CCK-8 测定、集落形成测定、划痕愈合测定和细胞凋亡测定来测试生物学功能。敲低 SNHG1 和过表达 miR-216b-5p 通过抑制细胞生长和迁移以及促进细胞凋亡来刺激 A2780/Taxol 细胞对紫杉醇的敏感性。抑制 miR-216b-5p 可挽救 lnc-SNHG1 抑制对 A2780/Taxol 细胞对紫杉醇敏感性的影响。荧光素酶报告测定、RNA 结合蛋白免疫沉淀测定(RIP)和定量逆转录聚合酶链反应(qRT-PCR)表明,lnc-SNHG1 在 A2780/Taxol 细胞中作为 miR-216b-5p 的海绵。

结论

本研究表明,lnc-SNHG1 的过表达和 miR-216b-5p 的表达水平降低与浆液性 EOC 患者的化疗耐药相关,并提示 OS 和 DFS 较短。lnc-SNHG1 作为 ceRNA 与 miR-216b-5p 相互作用,这在调节卵巢癌细胞对紫杉醇的敏感性中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/21c1a29f6b4c/13048_2020_750_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/a194953b198c/13048_2020_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/4895ad1b593f/13048_2020_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/d5451b75131c/13048_2020_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/6939e259b55f/13048_2020_750_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/21c1a29f6b4c/13048_2020_750_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/a194953b198c/13048_2020_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/4895ad1b593f/13048_2020_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/d5451b75131c/13048_2020_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/6939e259b55f/13048_2020_750_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac2/7731520/21c1a29f6b4c/13048_2020_750_Fig5_HTML.jpg

相似文献

1
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.lnc-SNHG1 和 miR-216b-5p 的失调与化疗耐药相关,并预示浆液性上皮性卵巢癌的不良预后。
J Ovarian Res. 2020 Dec 10;13(1):144. doi: 10.1186/s13048-020-00750-4.
2
The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.PAK2 的上调表明浆液性上皮性卵巢癌患者预后不良,并导致卵巢癌细胞对紫杉醇耐药。
BMC Cancer. 2024 Sep 30;24(1):1213. doi: 10.1186/s12885-024-12969-1.
3
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.LncRNA-SNHG1 通过调节 miR-216b-5p-己糖激酶 2 轴促进胃癌细胞对紫杉醇的耐药性。
J Chemother. 2023 Oct;35(6):527-538. doi: 10.1080/1120009X.2022.2157618. Epub 2022 Dec 22.
4
HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.HOXD-AS1 通过调节 miR-186-5p 和 PIK3R3 促进卵巢癌细胞的上皮间质转化。
J Exp Clin Cancer Res. 2019 Mar 1;38(1):110. doi: 10.1186/s13046-019-1103-5.
5
LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1.LINC01118 通过调节 miR-134/ABCC1 来调节上皮性卵巢癌对紫杉醇的耐药性。
Med Sci Monit. 2018 Dec 6;24:8831-8839. doi: 10.12659/MSM.910932.
6
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.微小RNA-133b靶向谷胱甘肽S-转移酶π的表达以增加卵巢癌细胞对化疗药物的敏感性。
Drug Des Devel Ther. 2015 Sep 16;9:5225-35. doi: 10.2147/DDDT.S87526. eCollection 2015.
7
LncRNA SNHG1 overexpression regulates the proliferation of acute myeloid leukemia cells through miR-488-5p/NUP205 axis.长链非编码 RNA SNHG1 通过 miR-488-5p/NUP205 轴调控急性髓系白血病细胞的增殖。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5896-5903. doi: 10.26355/eurrev_201907_18334.
8
Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.上调的lnc-SNHG1通过隔离miR-577和激活WNT2B/Wnt/β-连环蛋白通路促进骨肉瘤进展。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):238-245. doi: 10.1016/j.bbrc.2017.11.012. Epub 2017 Nov 8.
9
Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p.长链非编码RNA Linc00518通过隔离miR-216b-5p促进人前列腺癌对紫杉醇的耐药性。
Biol Cell. 2019 Feb;111(2):39-50. doi: 10.1111/boc.201800054. Epub 2018 Dec 7.
10
Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497.长链非编码 RNA-SNHG1 可能通过作为 miR-497 的海绵体促进非小细胞肺癌的进展。
Biochem Biophys Res Commun. 2018 Nov 30;506(3):632-640. doi: 10.1016/j.bbrc.2018.10.086. Epub 2018 Oct 25.

引用本文的文献

1
Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer.上皮性卵巢癌中导致耐药的长链非编码RNA的特征分析
Med Oncol. 2025 Feb 24;42(4):84. doi: 10.1007/s12032-025-02628-1.
2
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.卵巢癌中的长链非编码RNA:机制洞察与临床应用
Cancers (Basel). 2025 Jan 30;17(3):472. doi: 10.3390/cancers17030472.
3
The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.

本文引用的文献

1
Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.长链非编码 RNA SNHG1 通过调节 LMO4 促进乳腺癌的进展。
Oncol Rep. 2020 May;43(5):1503-1515. doi: 10.3892/or.2020.7530. Epub 2020 Mar 4.
2
SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway.SNHG1/miR-556-5p/TCF12 反馈环路通过 Wnt 信号通路增强脑膜瘤的肿瘤发生。
J Cell Biochem. 2020 Feb;121(2):1880-1889. doi: 10.1002/jcb.29423. Epub 2019 Nov 6.
3
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
PAK2 的上调表明浆液性上皮性卵巢癌患者预后不良,并导致卵巢癌细胞对紫杉醇耐药。
BMC Cancer. 2024 Sep 30;24(1):1213. doi: 10.1186/s12885-024-12969-1.
4
Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.预测化疗耐药性——临床前数据如何帮助修改高级别浆液性卵巢癌的治疗策略。
Curr Oncol. 2023 Dec 29;31(1):229-249. doi: 10.3390/curroncol31010015.
5
LncRNA SNHG1: role in tumorigenesis of multiple human cancers.长链非编码RNA SNHG1:在多种人类癌症肿瘤发生中的作用
Cancer Cell Int. 2023 Sep 8;23(1):198. doi: 10.1186/s12935-023-03018-1.
6
miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells.miR-216b-5p促进曲妥珠单抗耐药的SK-BR-3细胞发生晚期凋亡/坏死性凋亡。
Turk J Biol. 2023 May 23;47(3):199-207. doi: 10.55730/1300-0152.2655. eCollection 2023.
7
Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer.长链非编码RNA作为克服卵巢癌化疗耐药性的治疗靶点。
Front Cell Dev Biol. 2022 Aug 29;10:999174. doi: 10.3389/fcell.2022.999174. eCollection 2022.
8
lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN.长链非编码 RNA NBAT1 通过海绵吸附 miR-21-5p 调控 PTEN 抑制子宫内膜癌细胞转移并促进细胞凋亡。
Comput Math Methods Med. 2022 Jul 20;2022:9304392. doi: 10.1155/2022/9304392. eCollection 2022.
9
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.作为卵巢癌生物标志物的细胞外囊泡-ceRNAs:探究环状RNA-微小RNA-信使RNA编码
Cancers (Basel). 2022 Jul 13;14(14):3404. doi: 10.3390/cancers14143404.
10
Retraction: The Gene Is Overexpressed and Correlates with Increased White Blood Cell Count, Poor Induction Treatment Response, and Poor Survival Profile in Adult Acute Myeloid Leukemia.撤稿声明:该基因在成人急性髓系白血病中呈过表达状态,与白细胞计数升高、诱导治疗反应不良和生存预后不良相关。
Turk J Haematol. 2022 Aug 25;39(3):188-195. doi: 10.4274/tjh.galenos.2022.2022.0117. Epub 2022 Jun 3.
尼拉帕利联合一线化疗及维持治疗卵巢癌
N Engl J Med. 2019 Dec 19;381(25):2403-2415. doi: 10.1056/NEJMoa1909707. Epub 2019 Sep 28.
4
Release notice - Canadian Cancer Statistics 2019.发布通知 - 2019年加拿大癌症统计数据
Health Promot Chronic Dis Prev Can. 2019 Sep;39(8-9):255. doi: 10.24095/hpcdp.39.8/9.04.
5
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.微小 RNA let-7g 作为人类上皮性卵巢癌的肿瘤抑制因子和化疗耐药的预测生物标志物。
Sci Rep. 2019 Apr 5;9(1):5668. doi: 10.1038/s41598-019-42221-x.
6
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.长链非编码 RNA KB-1471A8.2 过表达抑制卵巢癌细胞增殖和迁移并拮抗紫杉醇耐药性。
Cancer Biother Radiopharm. 2019 Jun;34(5):316-324. doi: 10.1089/cbr.2018.2698. Epub 2019 Mar 20.
7
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.miR-142-5p 通过靶向多个抗凋亡基因增强卵巢癌细胞对顺铂的凋亡作用。
Biochem Pharmacol. 2019 Mar;161:98-112. doi: 10.1016/j.bcp.2019.01.009. Epub 2019 Jan 11.
8
MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy.miR-34c/SOX9 轴调控卵巢癌细胞对顺铂化疗的耐药性。
J Cell Biochem. 2019 Mar;120(3):2940-2953. doi: 10.1002/jcb.26865. Epub 2018 Dec 9.
9
Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway.lncRNA FER1L4的过表达通过调控MAPK信号通路抑制卵巢癌细胞对紫杉醇的耐受性。
J Cell Biochem. 2019 May;120(5):7581-7589. doi: 10.1002/jcb.28032. Epub 2018 Nov 15.
10
Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.miR-383-5p 的上调通过靶向 TRIM27 抑制卵巢癌细胞的增殖并增强其化疗敏感性。
Biomed Pharmacother. 2019 Jan;109:595-601. doi: 10.1016/j.biopha.2018.10.148. Epub 2018 Nov 3.